XOMA Corp Net Invested Capital Over Time
| XOMA Stock | USD 30.20 0.13 0.43% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out XOMA Corp Performance and XOMA Corp Correlation. XOMA |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of XOMA Corp. If investors know XOMA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about XOMA Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.37 | Earnings Share (3.07) | Revenue Per Share 1.862 | Quarterly Revenue Growth 7.671 | Return On Assets (0.06) |
The market value of XOMA Corp is measured differently than its book value, which is the value of XOMA that is recorded on the company's balance sheet. Investors also form their own opinion of XOMA Corp's value that differs from its market value or its book value, called intrinsic value, which is XOMA Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because XOMA Corp's market value can be influenced by many factors that don't directly affect XOMA Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between XOMA Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if XOMA Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XOMA Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Invested Capital Analysis
Compare XOMA Corp and related stocks such as Werewolf Therapeutics, Edgewise Therapeutics, and Decibel Therapeutics Net Invested Capital Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HOWL | (24.3 M) | (24.3 M) | (24.3 M) | (24.3 M) | (24.3 M) | (24.3 M) | (24.3 M) | (24.3 M) | (24.3 M) | (24.3 M) | (51.9 M) | 152.8 M | 122.3 M | 150.7 M | 76.9 M |
| EWTX | (16.9 M) | (16.9 M) | (16.9 M) | (16.9 M) | (16.9 M) | (16.9 M) | (16.9 M) | (16.9 M) | (16.9 M) | (16.9 M) | (33.4 M) | 274.4 M | 346.7 M | 318.8 M | 195.7 M |
| CELC | 31.4 M | 31.4 M | 31.4 M | 31.4 M | 31.4 M | 31.4 M | 31.4 M | 31.4 M | 25.3 M | 19.3 M | 11.7 M | 14.6 M | 168.8 M | 176.8 M | 185.6 M |
| CCCC | (79.8 M) | (79.8 M) | (79.8 M) | (79.8 M) | (79.8 M) | (79.8 M) | (79.8 M) | (79.8 M) | (79.8 M) | (112 M) | 290.8 M | 400.4 M | 300.7 M | 246.1 M | 191.8 M |
| THRD | (18.4 M) | (18.4 M) | (18.4 M) | (18.4 M) | (18.4 M) | (18.4 M) | (18.4 M) | (18.4 M) | (18.4 M) | (18.4 M) | (18.4 M) | (46.7 M) | 289.1 M | 269.1 M | 135.6 M |
| PASG | (12.2 M) | (12.2 M) | (12.2 M) | (12.2 M) | (12.2 M) | (12.2 M) | (12.2 M) | (12.2 M) | (12.2 M) | 174.4 M | 304.7 M | 318.7 M | 201.4 M | 111.3 M | 201.3 M |
| ACRV | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (23.8 M) | 170.5 M | 121.2 M | 71.4 M |
| RZLT | 8.5 M | 8.5 M | 8.5 M | 8.5 M | 8.5 M | 8.5 M | 8.5 M | (526.1 K) | 1.8 M | 7.4 M | 40.1 M | 149.5 M | 116.2 M | 121 M | 61 M |
| VINC | (44 K) | (44 K) | (44 K) | (44 K) | (44 K) | (44 K) | (44 K) | (44 K) | (44 K) | (44 K) | 57.7 M | 100.3 M | 47.7 M | 11.2 M | 10.7 M |
| STOK | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | 105.1 M | 224.4 M | 286.1 M | 217.8 M | 184.8 M | 159.6 M | 184.9 M |
| CRNX | (15 M) | (15 M) | (15 M) | (15 M) | (15 M) | (15 M) | (15 M) | (15 M) | 160.2 M | 117.1 M | 168.9 M | 331.9 M | 316.3 M | 539.1 M | 566.1 M |
| DYN | (4.9 M) | (4.9 M) | (4.9 M) | (4.9 M) | (4.9 M) | (4.9 M) | (4.9 M) | (4.9 M) | (4.9 M) | (13.4 M) | 342.4 M | 368.2 M | 252.4 M | 91.3 M | 86.7 M |
| RVMD | (67.7 M) | (67.7 M) | (67.7 M) | (67.7 M) | (67.7 M) | (67.7 M) | (67.7 M) | (67.7 M) | 96.7 M | (152.6 M) | 474.7 M | 602.6 M | 685.2 M | 1.8 B | 1.9 B |
| DSGN | (2.9 M) | (2.9 M) | (2.9 M) | (2.9 M) | (2.9 M) | (2.9 M) | (2.9 M) | (2.9 M) | (2.9 M) | (2.9 M) | (11.3 M) | 382.1 M | 327.3 M | 277.7 M | 214 M |
| TNGX | 38.6 M | 38.6 M | 38.6 M | 38.6 M | 38.6 M | 38.6 M | 38.6 M | 38.6 M | 38.6 M | 38.6 M | 38.6 M | 344.7 M | 249.5 M | 253.1 M | 243.6 M |
| ACHL | 101.3 M | 101.3 M | 101.3 M | 101.3 M | 101.3 M | 101.3 M | 101.3 M | 101.3 M | 101.3 M | 101.3 M | 189.2 M | 289.4 M | 197 M | 142.4 M | 202.3 M |
XOMA Corp and related stocks such as Werewolf Therapeutics, Edgewise Therapeutics, and Decibel Therapeutics Net Invested Capital description
The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.My Equities
My Current Equities and Potential Positions
| XOMA Corp | XOMA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 30.2
Check out XOMA Corp Performance and XOMA Corp Correlation. For information on how to trade XOMA Stock refer to our How to Trade XOMA Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
XOMA Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.